Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.
about
Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseasesTurning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentBoswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical dataEvaluation on potential contributions of protease activated receptors related mediators in allergic inflammation.Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in miceF2RL3 methylation in blood DNA is a strong predictor of mortality.Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota.Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells.Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.The roles of thrombin and protease-activated receptors in inflammation.Biased signaling of protease-activated receptors.Protease-activated receptor 4: from structure to function and back again.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Proteinases, Their Extracellular Targets, and Inflammatory Signaling.Regulation of intestinal permeability: The role of proteasesCathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice.Is Matrix Metalloproteinase-8 Activity in the Mucosal Barrier a Requirement for Leakage of Cecal Material in Peritonitis?Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: role of cathepsin G and protease-activated receptor-4.Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity.Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease.Increased Immunoreactivity of Cathepsins in the Rat Esophagus under Chronic Acid Reflux EsophagitisAberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis
P2860
Q26745775-A6CD0BA4-B758-4559-A9C0-F6BB1ADB3DC9Q27024397-0F426348-1751-4FE0-A9C0-FEF1A986B1A1Q28237079-D2E08248-0D85-4607-8A63-549AB81A69D2Q33614606-BDECB5D1-47BA-4A4D-84A6-16E94CAF9246Q34148307-AB12EFC1-4E5D-4A2C-908F-E627388508E2Q34171082-6971C1C3-F5CE-4CEE-9328-7E394A9D32BEQ34649151-D857804D-8AE8-4B29-BF92-66793C9CDC2DQ35799019-A1E54748-F378-45E7-AC2E-AD6A72417BF7Q36179133-C4887BCC-F0A1-4A92-96DA-EA6840461EF2Q36699701-A9E98B9C-C328-4276-8C40-B7BE09B5C844Q37910045-22D1D1C6-D32E-425F-AD74-1D8552AA4312Q38214613-62E68A70-45D4-4378-AFE0-D67FE4E06F9FQ38722647-FE154F71-08BB-4AE7-8C5F-11AF2010B2E4Q38950036-E3CC106E-9E46-4704-B6B7-F311BFBEDFA0Q38966192-BEA1A39A-DE5E-41C0-907B-BDAC5B35FF49Q39239228-8A277440-FDA2-431D-8164-445DD90079DBQ40161159-0AEBA9E3-FB4D-482F-AAC1-B7B6D843B96EQ42949214-A73E8AF6-31C5-4A7A-B2E4-98569B0E2A69Q43888872-C5C7DFDB-284E-4E22-9F49-8C8159E63E38Q44449242-C56F4433-7E00-43CB-B6D7-7CAA0BD5C38CQ45189883-6A89019B-D4D1-4E01-98BD-2208CD88945CQ47142348-DFBED956-D6F9-40BF-BBFA-BBD54B679118Q52610913-8EA45521-F4CA-4727-8C01-F4D209372074Q53244368-C9EB2E74-97E3-43A2-896E-75855196D4D8Q55268565-DF9BE9A2-4406-425D-ABF2-E6B6AFF1C212Q57203178-0D2BA660-CF11-4EC4-906F-5098D67309BDQ58780488-214544E5-DC7F-46CA-8AC6-933009A7F7A8
P2860
Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@en
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@nl
type
label
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@en
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@nl
prefLabel
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@en
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@nl
P2093
P2860
P1476
Luminal cathepsin g and protea ...... barrier in ulcerative colitis.
@en
P2093
Afifa Ait-Belgnaoui
Christel Cartier
Gilles Chaumaz
Jacques Moreau
Jean Escourrou
Krisztina Gecse
Laurent Ferrier
Lionel Bueno
Marta Dabek
Richard Roka
P2860
P304
P356
10.2353/AJPATH.2009.080986
P407
P577
2009-06-15T00:00:00Z